Skip to main content
. 2021 Jan 29;22(3):1356. doi: 10.3390/ijms22031356

Figure 5.

Figure 5

C21 did not alter IL-17 levels in the ischemic hemisphere. (A) C21 administration did not alter IL-17-producing microglia (Iba1+/Il-17+). (B) C21 did not alter CD4+/Th17 cells. One-way ANOVA (n = 5–6/group).